We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$82.5M
AUM Growth
+$17.6M
Cap. Flow
+$17.7M
Cap. Flow %
21.44%
Top 10 Hldgs %
81.1%
Holding
28
New
2
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$9.35M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$6.5M
3
HOOK
HOOKIPA Pharma
HOOK
+$5.79M
4
BTAI icon
BioXcel Therapeutics
BTAI
+$624K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.11%
2 Materials 4.76%
3 Industrials 2.96%
4 Financials 1.4%
5 Consumer Staples 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDX icon
1
Aldeyra Therapeutics
ALDX
$91.7M
$25.3M 30.67%
3,015,668
+948,508
+46% +$9.35M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.8M 13.06%
450,422
– –
AVDL
3
DELISTED
Avadel Pharmaceuticals
AVDL
$8.24M 9.99%
+500,000
New +$6.5M
HOOK
4
DELISTED
HOOKIPA Pharma
HOOK
$4.86M 5.89%
551,739
+521,739
+1,739% +$5.79M
APLT
5
DELISTED
Applied Therapeutics
APLT
$4.42M 5.35%
3,450,000
– –
VRNA
6
DELISTED
Verona Pharma
VRNA
$4.23M 5.13%
200,000
– –
GDX icon
7
VanEck Gold Miners ETF
GDX
$23B
$2.77M 3.35%
91,850
– –
SIL icon
8
Global X Silver Miners ETF NEW
SIL
$4.08B
$2.33M 2.83%
89,700
– –
ENTX icon
9
Entera Bio
ENTX
$101M
$2.09M 2.54%
2,484,275
– –
GDXJ icon
10
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
$1.9M 2.3%
53,150
– –
BAH icon
11
Booz Allen Hamilton
BAH
$8.7B
$1.45M 1.76%
13,000
– –
V icon
12
Visa
V
$677B
$1.15M 1.4%
4,850
– –
TMO icon
13
Thermo Fisher Scientific
TMO
$211B
$1.1M 1.33%
2,100
– –
OCUL icon
14
Ocular Therapeutix
OCUL
$1.86B
$1.03M 1.25%
200,000
– –
MO icon
15
Altria Group
MO
$122B
$1.03M 1.25%
22,700
– –
CVS icon
16
CVS Health
CVS
$137B
$1M 1.22%
14,500
– –
FNV icon
17
Franco-Nevada
FNV
$41.4B
$998K 1.21%
7,000
– –
SILV
18
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$996K 1.21%
170,000
– –
NOC icon
19
Northrop Grumman
NOC
$77B
$987K 1.2%
2,165
– –
OR icon
20
OR Royalties Inc
OR
$5.47B
$969K 1.17%
400,000
– –
OMGA
21
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$969K 1.17%
173,010
– –
SA
22
Seabridge Gold
SA
$2.8B
$964K 1.17%
80,000
– –
OCUL icon
23
CALL
Ocular Therapeutix
OCUL
$1.86B
$814K 0.99%
95,800
– –
ALT icon
24
Altimmune
ALT
$539M
$614K 0.74%
173,864
– –
IRD
25
Opus Genetics
IRD
$254M
$434K 0.53%
100,000
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Knoll Capital Management held 28 positions worth $82.5M, up 27% from $64.9M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Knoll Capital Management deployed $17.7M of net new capital in Q2 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Avadel Pharmaceuticals: 500,000 shares worth $8.24M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 66% a quarter earlier, followed by Materials and Industrials.

  • Knoll Capital Management's largest Q2 2023 buy was Avadel Pharmaceuticals: 500,000 shares worth $8.24M.
  • Knoll Capital Management added most to Aldeyra Therapeutics in Q2 2023, an estimated $9.35M increase.
  • Knoll Capital Management's ten largest holdings make up 81% of its $82.5M portfolio in Q2 2023.
  • Knoll Capital Management opened 2 new positions and closed 1 in Q2 2023.
  • Knoll Capital Management's portfolio value rose 27% quarter-over-quarter to $82.5M.

Based on Knoll Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.